Hap Trading, LLC Soleno Therapeutics Inc Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.14 - $0.23 $2,128 - $3,496	-15,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.22 - $0.47 $3,344 - $7,144	15,200 New	15,200 $1,000
Q4 2021 Feb 14, 2022	SELL	$0.41 - $0.91 $4,838 - $10,738	-11,800 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$0.8 - $1.12 $1,120 - $1,568	-1,400 Reduced 10.61%	11,800 $1,000
Q2 2021 Aug 11, 2021	BUY	$0.97 - $1.32 $12,804 - $17,424	13,200 New	13,200 $3,000
Q3 2020 Nov 13, 2020	SELL	$1.71 - $2.51 $22,059 - $32,378	-12,900 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$1.77 - $4.23 $22,833 - $54,567	12,900 New	12,900 $2,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.